These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33154553)
1. Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Zhu L; Zhang CY; Li DP; Chen HB; Ma J; Gao H; Ye Y; Wang JY; Fu PP; Lin G Acta Pharmacol Sin; 2021 Aug; 42(8):1212-1222. PubMed ID: 33154553 [TBL] [Abstract][Full Text] [Related]
2. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894 [TBL] [Abstract][Full Text] [Related]
3. Exposure to Gynura japonica (Thunb.) Juel plants induces hepatoxicity in rats and Buffalo rat liver cells. Wen C; Zhou T; Chang Y; Wei Y; Zhang H; Yang Z J Ethnopharmacol; 2024 Dec; 335():118692. PubMed ID: 39151710 [TBL] [Abstract][Full Text] [Related]
4. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica. Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501 [TBL] [Abstract][Full Text] [Related]
5. Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis. Wang W; Yang X; Chen Y; Ye X; Jiang K; Xiong A; Yang L; Wang Z J Appl Toxicol; 2020 Nov; 40(11):1534-1544. PubMed ID: 32618019 [TBL] [Abstract][Full Text] [Related]
6. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Wang X; Zhang W; Yang Y; Chen Y; Zhuge Y; Xiong A; Yang L; Wang Z Front Pharmacol; 2021; 12():627126. PubMed ID: 33679405 [No Abstract] [Full Text] [Related]
7. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors. Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152 [TBL] [Abstract][Full Text] [Related]
8. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783 [TBL] [Abstract][Full Text] [Related]
9. Tusanqi and hepatic sinusoidal obstruction syndrome. Wang JY; Gao H J Dig Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24528632 [TBL] [Abstract][Full Text] [Related]
10. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice. Xiong A; Shao Y; Fang L; Yang X; Zhang S; Zheng J; Ding W; Yang L; Wang Z Phytomedicine; 2019 Feb; 54():77-88. PubMed ID: 30668385 [TBL] [Abstract][Full Text] [Related]
12. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Cen P; Ding J; Jin J J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome. Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243 [TBL] [Abstract][Full Text] [Related]
14. Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Xiong A; Lu L; Jiang K; Wang X; Chen Y; Wang X; Zhang W; Zhuge Y; Huang W; Li L; Liao Q; Yang F; Liu P; Ding L; Wang Z; Yang L Arch Toxicol; 2024 Aug; 98(8):2557-2576. PubMed ID: 38703205 [TBL] [Abstract][Full Text] [Related]
15. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. Yang XQ; Ye J; Li X; Li Q; Song YH World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770 [TBL] [Abstract][Full Text] [Related]
16. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Zhuge Y; Liu Y; Xie W; Zou X; Xu J; Wang J; J Gastroenterol Hepatol; 2019 Apr; 34(4):634-642. PubMed ID: 30669184 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Teschke R; Vongdala N; Quan NV; Quy TN; Xuan TD Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638760 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495 [TBL] [Abstract][Full Text] [Related]
19. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts. Ma J; Li M; Li N; Chan WY; Lin G Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016 [TBL] [Abstract][Full Text] [Related]
20. Mass-spectrometry-directed analysis and purification of pyrrolizidine alkaloid cis/trans isomers in Gynura japonica. Fang L; Xiong A; Yang X; Cheng W; Yang L; Wang Z J Sep Sci; 2014 Aug; 37(15):2032-8. PubMed ID: 24840731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]